Type of carbohydrate in feed affects the expression of small leucine-rich proteoglycans (SLRPs), glycosaminoglycans (GAGs) and interleukins in skeletal muscle of Atlantic cod (Gadus morhua L.)

Fish and Shellfish Immunology

Volumn 33, Issue 3, 2012, Pages 582-589

  Tingbo M G ^a   Pedersen, M E ^a   Grondahl F ^b   Kolset, S O ^c   Veiseth Kent, E ^a   Enersen, G ^a   Hannesson, K O ^a  

^a NOFIMA   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Cod muscle; Glycosaminoglycans; Hyperglycemia; Inflammation; Proteoglycans

Indexed keywords

GADUS MORHUA;

EID: 84864395354     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2012.06.025     Document Type: Article

References (55)

1. Comper W.D., Laurent T.C. Physiological function of connective tissue polysaccharides. Physiol Rev 1978, 58:255-315.
2. Kreuger J., Spillmann D., Li J.P., Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 2006, 174:323-327.
3. Lindahl U., Li J.P. Interactions between heparan sulfate and proteins - design and functional implications. Int Rev Cell Mol Biol 2009, 276:105-159.
4. Iozzo R.V. Series introduction: heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 2001, 108:165-167.
5. Kalamajaski S., Oldberg Å. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol 2010, 29:248-253.
6. Merline R., Schaefer R.M., Schaefer L. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Comm Sign 2009, 3:323-335.
7. Zhang G., Chen S., Goldoni S., Calder B.W., Simpson H.C., Owens R.T., et al. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem 2009, 284:8888-8897.
8. Danielson K.G., Baribault H., Holmes D.F., Graham H Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743.
9. Chakravarti S. Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J 2003, 19:287-293.
10. Young M.F., Bi Y., Chen X.-D. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 2003, 19:257-262.
11. Brandan E., Cabello-Verrugio C., Vial C. Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol 2008, 27:700-708.
12. Babelova A., Moreth K., Tsalastra-Greul W., Zeng-Brouwers J., Eickelberg O., Young M.F., et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors. J Biol Chem 2009, 284:24035-24048.
13. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., et al. The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005, 115:2223-2233.
14. Iozzo R.V., Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 2010, 277:3864-3875.
15. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhão J.G., et al. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 2011, 4. ra75.
16. Sjöberg A., Onnerfjord P., Mörgelin M., Heinegård D., Blom A.M. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem 2005, 280:32301-32308.
17. Sjöberg A.P., Manderson G.A., Mörgelin M., Day A.J., Heinegård D., Blom A.M. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol 2009, 46:830-839.
18. Miragliotta V., Raphäel K., Lussier J.G., Theoret C.L. Equine lumican (LUM) cDNA sequence and spatio-temporal expression in an experimental model of normal and pathological wound healing. ESVD and ACVD 2008, 20:243-248.
19. Yeh J.T., Yeh L.K., Jung S.M., Chang H.H., Wu T.F., Shiu C.Y., et al. Impaired skin wound healing in lumican-null mice. British J Dermatol 2010, 163:1174-1180.
20. Wolf G., Ziyadeh F.N. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007, 106:26-31.
21. Tsilibary E.C. Microvascular basement membranes in diabetes mellitus. J Pathol 2003, 200:537-546.
22. Camejo G., Olsson U., Hurt-Camejo E., Baharamian N., Bondjers G. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atheroscl Suppl 2002, 3:3-9.
23. Wasty F., Alavi M.Z., Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 1993, 36:316-322.
24. Edge A.S., Spiro R.G. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes. Diabetologica 2000, 43:1056-1059.
25. Salmon A.H., Satchell S.C. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 2012, 226:562-574.
26. Cechowska-Pasko M., Wolanska M., Palka J. Glycosaminoglycan-degrading enzymes in the skin of fasted rats. Comp Biochem Physiol 2002, 131B:551-557.
27. Cechowska-Pasko M., Pałka J., Bańkowski E. Decreased biosynthesis of glycosaminoglycans in the skin of rats with chronic diabetes mellitus. Exp Toxicol Pathol 1999, 51:239-243.
28. Zeyda M., Stulnig T.M. Obesity, inflammation, and insulin resistance - a mini-review. Gerontology 2009, 55:379-386.
29. Dinarello C.A. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 2011, 41:1203-1217.
30. Maedler K., Dharmadhikari G., Schumann D.M., Størling J. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes. Handb Exp Pharmacol 2011, 203:257-278.
31. Dinarello C.A. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 2009, 360:2467-2470.
32. Rosenlund G., Karlsen Ø., Tveit K., Mangor-Jensen A., Hemre G.I. Effect of feed composition and feeding frequency on growth, feed utilization and nutrient retention in juvenile Atlantic cod, Gadus morhua L. Aquacult Nutr 2004, 10:371-378.
33. Hemre G.I., Mommsen T.P., Krogdahl A. Carbohydrates in fish nutrition: effects on growth, glucose metabolism and hepatic enzymes. Aquacult Nutr 2002, 8:175-194.
34. Krogdahl Å., Hemre G.I., Mommsen T.P. Carbohydrates in fish nutrition: digestion and absorption in postlarval stages. Aquacult Nutr 2005, 11:103-122.
35. Karlsen Ø., Hemre G.I., Tveit K., Rosenlund G. Effect of varying levels of macro-nutrients and continuous light on growth, energy deposits and maturation in farmed Atlantic cod (Gadus morhua L.). Aquaculture 2006, 255:242-254.
36. Enes P., Panserat S., Kaushik S., Oliva-Teles A. Nutritional regulation of hepatic glucose metabolism in fish. Fish Physiol Biochem 2009, 35:519-539.
37. Tingbø M.G., Kolset S.O., Ofstad R., Enersen G., Hannesson K.O. Identification and distribution of heparan sulfate proteoglycans in the white muscle of Atlantic cod (Gadus morhua) and spotted wolffish (Anarhichas minor). Comp Biochem Physiol 2006, 143B:441-452.
38. Tingbø M.G., Pedersen M.E., Enersen G., Kolset S.O., Hannesson K.O. Lumican is a major small leucine-rich proteoglycan (SLRP) in Atlantic cod (Gadus morhua L.) muscle. Glycoconj J 2012, 29:13-23.
39. Hannesson K.O., Tingbø M.G., Olsen R.L., Enersen G., Bævre A.B., Ofstad R. An immunological study of glycosaminoglyans in the connective tissue of bovine and cod skeletal muscle. Comp Biochem Physiol 2007, 146B:512-520.
40. Scott J.E., Dorling J. Differential staining of acid glycosaminoglycans (mucoplysaccharides) by Alcian blue in salt solutions. Histochemie 1965, 5:221-233.
41. Ledin J., Staatz W., Li J.P., Götte M., Selleck S., Kjellén L., et al. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem 2004, 279:42731-42741.
42. Grøndahl F., Tveit H., Prydz K. Neutralization of endomembrane compartments in epithelial MDCK cells affects proteoglycan synthesis in the apical secretory pathway. Biochem J 2009, 418:517-528.
43. Lawrence R., Lu H., Rosenberg R.D., Esko J.D., Zhang L. Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods 2008, 5:291-292.
44. Banerjee M., Saxena M. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Invest 2012, 413:1163-1170.
45. Johnston I. Muscle development and growth: potential implications for flesh quality in fish. Aquaculture 1999, 177:99-115.
46. Ashton T.J., Michie I., Johnston I. A novel tensile test method to assess texture and gaping in salmon fillets. J Food Sci 2010, 75:182-190.
47. Sato K., Ohashi C., Ohtsuki K., Kawabata M. Type V collagen in trout (Salmo gairdneri) muscle and its solubility change during chilled storage of muscle. J Agric Food Chem 1991, 39:1222-1225.
48. Kim K., Haard N.F. Degradation of proteoglycans in the skeletal muscle of Pacific rockfish (Sebastes sp.) during ice storage. J Muscle Foods 1992, 3:103-121.
49. Olsson G.B., Ofstad R., Lødemel J.B., Olsen R.L. Changes in water-holding capacity of halibut muscle during cold storage. LWT 2003, 36:771-778.
50. Ofstad R., Olsen R.L., Taylor R., Hannesson K. Breakdown of intramuscular connective tissue in cod (Gadus morhua) and spotted wolffish (Anarhichas minor O.) related to gaping. LWT 2006, 39:1143-1154.
51. Tingbo M.G., Kolset S.O., Ofstad R., Enersen G., Hannesson K.O. Sulfated glycosaminoglycans in the extracellular matrix of muscle tissue in Atlantic cod (Gadus morhua) and Spotted wolffish (Anarhichas minor). Comp Biochem Physiol 2005, 140B:349-357.
52. Mogyorosi A., Ziyadeh F.N. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 1998, 275:F827-F832.
53. Schaefer L., Raslik I., Gröne H.J., Schönherr E., Macakova K., Ugorcakova J., et al. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 2001, 15:559-561.
54. Chen C.P., Chang S.C., Yang W.C.V. High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 2007, 28:97-106.
55. Klein D.J., Cohen R.M., Rymaszewski Z. Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. J Cell Physiol 1995, 165:493-502.